Short-term therapy for mixed vaginal infections.
Villagrana-Zesati
R
R
Department of Infectology and Immunology. National Institute of Perinatology, Mexico City, Mexico. dr_robertovillagrana@hotmail.com
Reyna-Figueroa
J
J
Ortiz-Ibarra
J
J
D000284:Administration, Oral; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000994:Antitrichomonal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002181:Candidiasis, Vulvovaginal / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D015725:Fluconazole / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D017964:Itraconazole / Q000008:administration & dosage / Q000627:therapeutic use; D008795:Metronidazole / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D010349:Patient Compliance; D014011:Tinidazole / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome; D014247:Trichomonas Vaginitis / Q000150:complications / Q000188:drug therapy*; D016585:Vaginosis, Bacterial / Q000150:complications / Q000188:drug therapy*
D000935:Antifungal Agents; D000981:Antiprotozoal Agents; D000994:Antitrichomonal Agents; D014011:Tinidazole; D008795:Metronidazole; D017964:Itraconazole; D015725:Fluconazole; C016724:secnidazole